Soy protein supplementation does not cause lymphocytopenia in postmenopausal women

Nutrition Journal

Volumn 5, Issue , 2006, Pages

  Soung, Do Y ^b   Patade, Anagha ^b   Khalil, Dania A ^b   Lucas, Edralin A ^b   Devareddy, Latha ^a   Greaves, Kathryn A ^c   Arjmandi, Bahram H ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

^b OKLAHOMA STATE UNIVERSITY   (United States)

^c Solae Company   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOFLAVONE DERIVATIVE; SOYBEAN PROTEIN;

ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MEAN CORPUSCULAR HEMOGLOBIN; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; VENOUS BLOOD;

AGED; BASOPHILS; DIET; ERYTHROCYTE INDICES; FEMALE; HUMANS; ISOFLAVONES; LEUKOCYTE COUNT; LYMPHOPENIA; MIDDLE AGED; MONOCYTES; PLATELET COUNT; POSTMENOPAUSE; SOYBEAN PROTEINS;

EID: 33745387617     PISSN: 14752891     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-5-12     Document Type: Article

References (22)

1. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JWJ: Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998, 68:1375S-1379S.
2. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T: Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 2000, 72:844-852.
3. Squadrito F, Altavilla D, Crisafulli A, Saitta A, Cucinotta D, Morabito N, D'Anna R, Corrado F, Ruggeri P, Frisina N, Squadrito G: Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study. Am J Med 2003, 114:470-476.
4. Goodman-Gruen D, Kritz-Silverstein D: Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr 2001, 131:1202-1206.
5. Crisafulli A, Altavilla D, Squadrito G, Romeo A, Adamo EB, Marini R, Inferrera MA, Marini H, Bitto A, D'Anna R, Corrado F, Bartolone S, Frisina N, Squadrito F: Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin system in early postmenopausal women. J Clin Endocrinol Metab 2004, 89:188-192.
6. Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F: Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res 2002, 17:1904-1912.
7. Dalais FS, Rice GE, Wahlqvist ML, Grehan M, Murkies AL, Medley G, Ayton R, Strauss BJ: Effects of dietary phytoestrogens in postmenopausal women. Climacteric 1998, 1:124-129.
8. Gallagher JC, Satpathy R, Rafferty K, Haynatzka V: The effect of soy protein isolate on bone metabolism. Menopause 2004, 11:290-298.
9. Vitolins M, Anthony M, Lenschik L, Bland DR, Burke GL: Does soy protein and its isoflavones prevent bone loss in peri- and postmenopausal women? Results of a two year randomized clinical trial. J Nutr 2002, 132:582S.
10. E LO, JBE J, KD S, TH J: Soymilk or progesterone for the prevention of bone loss. A 2 year randomized, placebo-controlled trial. European Journal of Nutrition 2004, 12:12.
11. Chiechi LM, Secreto G, D'Amore M, Fanelli M, Venturelli E, Cantatore F, Valerio T, Laselva G, Loizzi P: Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial. Maturitas 2002, 42:295-300.
12. Alexandersen P, Toussaint A, Christiansen C, Devogelaer JP, Roux C, Fechtenbaum J, Gennari C, Reginster JY: Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. JAMA 2001, 285:1482-1488.
13. Agnusdei D, Bufalino L: Efficacy of ipriflavone in established osteoporosis and long-term safety. Calcif Tissue Int 1997, 61 Suppl 1:S23-S27.
14. Soung DY, Khalil DA, Arquitt AB, Smith BJ, Hammond LJ, Droke EA, Lucas EA, Devareddy L, Arjmandi BH: Soy isoflavones prevent the ovarian hormone deficiency-associated rise in leukocytes in rats. Phytomedicine 2004, 11:303-308.
15. Arjmandi BH, Lucas EA, Khalil DA, Devareddy L, Smith BJ, McDonald J, Arquitt AB, Payton ME, Mason C: One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women. Nutr J 2005, 4:8.
16. Ben Hur H, Mor G, Insler V, Blickstein I, Amir-Zaltsman Y, Sharp A, Globerson A, Kohen F: Menopause is associated with a significant increase in blood monocyte number and a relative decrease in the expression of estrogen receptors in human peripheral monocytes. Am J Reprod Immunol 1995, 34:363-369.
17. Giglio T, Imro MA, Filaci G, Scudeletti M, Puppo F, De Cecco L, Indiveri F, Costantini S: Immune cell circulating subsets are affected by gonadal function. Life Sci 1994, 54:1305-1312.
18. Ishimi Y, Miyaura C, Ohmura M, Onoe Y, Sato T, Uchiyama Y, Ito M, Wang X, Suda T, Ikegami S: Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology 1999, 140:1893-1900.
19. Moxley G, Stern AG, Carlson P, Estrada E, Han J, Benson LL: Pre-menopausal sexual dimorphism in lipopolysaccharide-stimulated production and secretion of tumor necrosis factor. J Rheumatol 2004, 31:686-694.
20. Rogers A, Eastell R: The effect of 17beta-estradiol on production of cytokines in cultures of peripheral blood. Bone 2001, 29:30-34.
21. Viswanath D, Hegde R, Murthy V, Nagashree S, Shah R: Red cell distribution width in the diagnosis of iron deficiency anemia. Indian J Pediatr 2001, 68:1117-1119.
22. Hough HJ, Failla ML, Ludwig DA: Active lifestyle offsets HRT-induced suppression of T cell reactivity to mitogens. Maturitas 1999, 33:211-218.